We are live on ! Find out more

2,990 hedge funds and large institutions have $163B invested in Merck in 2022 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 1,374 increasing their positions, 1,114 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $2.42B | Put options by funds: $1.79B

23% more repeat investments, than reductions

Existing positions increased: 1,374 | Existing positions reduced: 1,114

16% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 104

0.78% more ownership

Funds ownership: 74.29%75.08% (+0.78%)

1% less funds holding

Funds holding: 3,0142,990 (-24)

4% less capital invested

Capital invested by funds: $171B → $163B (-$7.45B)

6% less funds holding in top 10

Funds holding in top 10: 238224 (-14)

Holders
2,990
Holders Change
-24
Holders Change %
-0.8%
% of All Funds
51.5%
Holding in Top 10
224
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.88%
% of All Funds
3.86%
New
121
Increased
1,374
Reduced
1,114
Closed
104
Calls
$2.42B
Puts
$1.79B
Net Calls
+$627M
Net Calls Change
+$85.4M
Name Holding Trade Value Shares
Change
Change in
Stake
National Bank of Canada
176
National Bank of Canada
Quebec, Canada
$92.5M +$46.5M +521,004 +94%
ZIM
177
Zacks Investment Management
Illinois
$91.6M +$2.5M +28,056 +3%
Teacher Retirement System of Texas
178
Teacher Retirement System of Texas
Texas
$91.2M +$11M +123,009 +13%
ASC
179
Atalanta Sosnoff Capital
New York
$90.5M -$8.09M -90,650 -8%
Handelsbanken Fonder
180
Handelsbanken Fonder
Sweden
$89.4M +$7.9M +88,503 +9%
Mirae Asset Global Investments
181
Mirae Asset Global Investments
South Korea
$89M +$7.14M +79,967 +8%
GC
182
Guggenheim Capital
Illinois
$86.2M -$21.8K -244 -0%
PCM
183
Penserra Capital Management
California
$85.2M +$26M +291,569 +42%
Bank of Nova Scotia
184
Bank of Nova Scotia
Ontario, Canada
$84.8M -$2.87M -32,186 -3%
HTC
185
Haverford Trust Company
Pennsylvania
$84.8M +$1.53M +17,143 +2%
WP
186
Woodline Partners
California
$84.3M +$36.8M +412,503 +73%
CCMG
187
Clark Capital Management Group
Pennsylvania
$84.1M -$7.93M -88,806 -8%
Capital International Investors
188
Capital International Investors
California
$82.9M +$207K +2,324 +0.2%
FMI
189
Factory Mutual Insurance
Massachusetts
$81.8M -$9M -100,771 -10%
CIBC World Market
190
CIBC World Market
Ontario, Canada
$81.6M +$2.11M +23,673 +3%
GT
191
Glenmede Trust
Pennsylvania
$81.2M +$11.1M +123,882 +15%
FAF
192
Fjarde Ap-fonden
Sweden
$81M
CB
193
Commerce Bank
Missouri
$79.9M +$3.35M +37,573 +4%
ELC
194
Edgar Lomax Company
Virginia
$76.1M -$594K -6,650 -0.7%
QP
195
Quilter Plc
United Kingdom
$75.8M +$3M +33,579 +4%
TAM
196
Tocqueville Asset Management
New York
$75.4M -$113K -1,269 -0.1%
Royal London Asset Management
197
Royal London Asset Management
United Kingdom
$75.2M -$4.84M -54,262 -6%
PAM
198
Panagora Asset Management
Massachusetts
$74.9M -$40.4M -452,962 -34%
Jennison Associates
199
Jennison Associates
New York
$74.6M -$69.1M -773,717 -47%
Fifth Third Bancorp
200
Fifth Third Bancorp
Ohio
$73.9M -$314K -3,513 -0.4%

MRK Hedge Fund Activity: Q3 2022 in Review

2,990 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2022, worth a combined $163B — down 4.4% from $171B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new MRK positions and 104 closed out — a net gain of 17 holders — while 1,374 added to existing stakes and 1,114 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $1.47B. The largest seller was Marshall Wace, cutting an estimated $459M.

  • 2,990 institutional investors held Merck (MRK) as of Q3 2022, down from 3,014 in Q2 2022.
  • Funds reported $163B of Merck stock for Q3 2022, down 4.4% quarter-over-quarter.
  • 121 funds opened new Merck positions in Q3 2022 and 104 closed out, a net change of +17 holders.
  • The largest Merck buyer in Q3 2022 was Janus Henderson Group, an estimated $1.47B added.
  • The largest Merck seller in Q3 2022 was Marshall Wace, an estimated $459M sold.

Based on aggregated 13F filings for Q3 2022.